Impact BioMedical Inc (AMEX:IBO) price on current trading day, rose 97.20% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.79.
A look at the stock’s price movement, the level at last check in today’s session was $0.40, moving within a range at $0.4601 and $0.9111. Turning to its 52-week performance, $6.17 and $0.37 were the 52-week high and 52-week low respectively. Overall, IBO moved 38.39% over the past month.
Impact BioMedical Inc’s market cap currently stands at around $9.07 million, with investors looking forward to this quarter’s earnings report slated for in June.
IBO’s current price about 51.30% and -29.26% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.35, while 7-day volatility ratio is 7.08% and 17.44% in the 30-day chart. Further, Impact BioMedical Inc (IBO) has a beta value of 0, and an average true range (ATR) of 0.25.
If we refocus on Impact BioMedical Inc (AMEX:IBO), historical trading data shows that trading volumes averaged 0.57 over the past 10 days and 6.17 million over the past 3 months. The company’s latest data on shares outstanding shows there are 11.50 million shares.
The 12.50% of Impact BioMedical Inc’s shares are in the hands of company insiders while institutional holders own 0.66% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.12 million on 2025-04-15, giving us a short ratio of 0.01. The data shows that as of 2025-04-15 short interest in Impact BioMedical Inc (IBO) stood at 184.0 of shares outstanding, with shares short rising to 9001.0 registered in 2025-03-14. Current price change has pushed the stock -45.60% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IBO stock continues to rise going into the next quarter.
